Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BASF Acquires Pronova - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

BASF Acquires Pronova

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

After increasing its cash offer to purchase Norwegian fish oil manufacturer Pronova BioPharma, BASF has secured more than 97% acceptance from shareholders. Based on all outstanding shares and including all net financial liabilities, the enterprise value would be approximately €684 million. All regulatory approvals required for completion of the offer have been obtained.

With the acquisition of Pronova, BASF will achieve a leading position in the global market for omega 3 fatty acids. Pronova will become a key part of BASF’s omega 3 business. Pronova’s active pharmaceutical ingredients are used to treat cardiovascular diseases such as post-myocardial infarction. In nutritional applications, including dietary supplements, there is a strong body of evidence supporting a broad range of positive health benefits through omega 3 fatty acids, for example, in the areas of cognitive development and heart health.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics